Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Elham Beyranvand Nejad, Marij J.P. Welters, Ramon Arens & Sjoerd H. van der Burg. (2017) The importance of correctly timing cancer immunotherapy. Expert Opinion on Biological Therapy 17:1, pages 87-103.
Read now
Read now
Edith MG van Esch, Marij JP Welters, Ekaterina S Jordanova, J Baptist MZ Trimbos, Sjoerd H van der Burg & Mariëtte IE van Poelgeest. (2012) Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy. Expert Review of Vaccines 11:7, pages 821-840.
Read now
Read now
Elizabeth A Mittendorf, Gheath Alatrash, Haile Xiao, G Travis Clifton, James L Murray & George E Peoples. (2011) Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials. Expert Review of Vaccines 10:6, pages 755-774.
Read now
Read now
Elizabeth A Mittendorf & Padmanee Sharma. (2010) Mechanisms of T-cell inhibition: implications for cancer immunotherapy. Expert Review of Vaccines 9:1, pages 89-105.
Read now
Read now
Alison H Banham & Karen Pulford. (2009) Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581. Expert Opinion on Therapeutic Patents 19:7, pages 1023-1028.
Read now
Read now
Articles from other publishers (11)
Minglei Zhuo, Hanxiao Chen, Tianzhuo Zhang, Xue Yang, Jia Zhong, Yuyan Wang, Tongtong An, Meina Wu, Ziping Wang, Jing Huang & Jun Zhao. (2018) The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients. Cancer Biomarkers 22:3, pages 467-476.
Crossref
Crossref
Yishu Tang, Wenbo Ma, Chunxia Zhou, Dongmei Wang & Shuren Zhang. (2018) A tritherapy combination of inactivated allogeneic leukocytes infusion and cell vaccine with cyclophosphamide in a sequential regimen enhances antitumor immunity. Journal of the Chinese Medical Association 81:4, pages 316-323.
Crossref
Crossref
Saskia J. A. M. Santegoets, Eveline M. Dijkgraaf, Alessandra Battaglia, Philipp Beckhove, Cedrik M. Britten, Awen Gallimore, Andrew Godkin, Cecile Gouttefangeas, Tanja D. de Gruijl, Hans J. P. M. Koenen, Alexander Scheffold, Ethan M. Shevach, Janet Staats, Kjetil Task?n, Theresa L. Whiteside, Judith R. Kroep, Marij J. P. Welters & Sjoerd H. van der Burg. (2015) Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry. Cancer Immunology, Immunotherapy 64:10, pages 1271-1286.
Crossref
Crossref
Joanna Rossowska, Elżbieta Pajtasz-Piasecka, Natalia Anger, Justyna Wojas-Turek, Jagoda Kicielińska, Egbert Piasecki & Danuta Duś. (2014) Cyclophosphamide and IL-12-transduced DCs Enhance the Antitumor Activity of Tumor Antigen–stimulated DCs and Reduce Tregs and MDSCs Number. Journal of Immunotherapy 37:9, pages 427-439.
Crossref
Crossref
Marij J.P. Welters & Sjoerd H. van der Burg. 2013. Cancer Immunotherapy. Cancer Immunotherapy
241
258
.
Panagiotis TsirigotisReuven Or, Igor B Resnick & Michael-Yechiel Shapira. (2012) Immunotherapeutic approaches to improve graft-versus-tumor effect and reduce graft-versus-host disease. Immunotherapy 4:4, pages 407-424.
Crossref
Crossref
Richard A. Peterson. (2012) Regulatory T-Cells: Diverse Phenotypes Integral to Immune Homeostasis and Suppression. Toxicologic Pathology 40:2, pages 186-204.
Crossref
Crossref
Cedrik Britten, Sylvia Janetzki, Cécile Gouttefangeas, Marij Welters, Michael Kalos, Christian Ottensmeier, Axel Hoos & Sjoerd van der Burg. 2011. Cancer Vaccines. Cancer Vaccines
156
166
.
Cedrik M. Britten, Sylvia Janetzki, Cécile Gouttefangeas, Marij J. P. Welters, Michael Kalos, Christian Ottensmeier, Axel Hoos & Sjoerd H. van der Burg. 2011. Cancer Vaccines: From Research to Clinical Practice. Cancer Vaccines: From Research to Clinical Practice
156
166
.
Xinxin Song, Wenzhong Guo, Jianfeng Cui, Xinlai Qian, Linan Yi, Mengjiao Chang, Qiliang Cai & Qingzheng Zhao. (2010) A tritherapy combination of a fusion protein vaccine with immune‐modulating doses of sequential chemotherapies in an optimized regimen completely eradicates large tumors in mice. International Journal of Cancer 128:5, pages 1129-1138.
Crossref
Crossref
Osama E Rahma, Ed Ashtar, Ramy Ibrahim, Antoun Toubaji, Barry Gause, Vincent E Herrin, W Marston Linehan, Seth M Steinberg, Frank Grollman, George Grimes, Sarah A Bernstein, Jay A Berzofsky & Samir N Khleif. (2010) A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma. Journal of Translational Medicine 8:1.
Crossref
Crossref